Dark Forest Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $1,926 - $2,785	17 Added 1.07%	1,605 $253,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $148,795 - $224,749	1,588 New	1,588 $205,000
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $375,765 - $453,080	3,666 Added 65.91%	9,228 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $274,299 - $405,235	-2,578 Reduced 31.67%	5,562 $636,000
Q1 2023 May 12, 2023	SELL	$117.53 - $155.99 $524,888 - $696,651	-4,466 Reduced 35.43%	8,140 $1.12 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $1.18 Million - $1.55 Million	11,736 Added 1348.97%	12,606 $1.63 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $61,097 - $96,226	807 Added 1280.95%	870 $96,000
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $3,949 - $5,571	63 New	63 $5,000
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $10,988 - $15,733	-174 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $2,782 - $3,579	-36 Reduced 17.14%	174 $16,000
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $13,853 - $19,420	210 New	210 $19,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.